Clenergen Corporation (CRGE) has released an update.
Charge Enterprises, Inc. has received Nasdaq’s nod to shift its common stock listing from the Nasdaq Global Market to the Nasdaq Capital Market, effective February 14, 2024, under its existing ticker “CRGE.” This move comes after a warning of non-compliance with Nasdaq’s minimum bid price rule, prompting the company to seek an additional 180 days to meet the requirement. If granted, the company must maintain a minimum $1.00 bid price for ten consecutive days within this period to avoid delisting. Charge Enterprises is exploring options to rectify the situation and maintain compliance with Nasdaq’s listing standards.
For further insights into CRGE stock, check out TipRanks’ Stock Analysis page.